45 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
IronNet, Inc. (NYSE: IRNT) shares jumped 50.4% to $25.06 after jumping over 23% on Friday.
23 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
IronNet, Inc. (NYSE: IRNT) rose 89.7% to $31.61 in pre-market trading after jumping over 23% on Friday.
Jaguar Health Stock Is Trading Lower In Reaction To Reverse Stock Split
Jaguar Health Inc (NASDAQ:JAGX) will effect a reverse stock split of its issued and outstanding voting common stock at an exchange…
Jaguar Health, Inc. Announces 1-for-3 Reverse Stock Split, To Begin Trading On Split-Adjusted Basis On Sept. 8, 2021
Reverse split approved by majority of common stock shareholders at December 2020 special meeting of stockholders
Shares of Jaguar common stock to begin trading on split-adjusted basis on September 8, 2021
Jaguar
Jaguar Health Subsidiary Napo Pharmaceuticals Submits Late-Breaking Abstract For Consideration For Presentation At 2021 IDWeek Annual Meeting
Napo Pharmaceuticals, the wholly-owned subsidiary of Jaguar Health, Inc. (NASDAQ:JAGX) today announced that an abstract associated with an exploratory clinical study on the effect of crofelemer (Mytesi®) on the
Jaguar Health Shares Move Higher; Co’s Subsidiary Napo Pharmaceuticals Signs License Agreement With Italian Subsidiary, Napo EU S.p.A., To Develop And Commercialize Crofelemer And Lechlemer In Europe
Napo Pharmaceuticals, Inc. (Napo), the wholly owned US subsidiary of Jaguar Health, Inc. (NASDAQ:JAGX), today announced the signing of a license agreement with Napo's Italian subsidiary, Napo EU S.p.A., to study,
The Daily Biotech Pulse: Moderna’s Vaccine Produces Durable Response Against Variants, FDA Approves Jazz’s Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 12)
Recap: Jaguar Health Q2 Earnings
Shares of Jaguar Health (NASDAQ:JAGX) moved higher by 1.5% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share rose 77.27% year over year to ($0.10), which missed the estimate of ($0.03).